Ulcerative ColitisSymptoms, Doctors, Treatments, Advances & More
Ulcerative Colitis Overview
Learn About Ulcerative Colitis
Perelman Center For Advanced Medicine South Pavilion
Gary Lichtenstein is a Gastroenterologist practicing medicine in Philadelphia, Pennsylvania. Dr. Lichtenstein is rated as an Elite provider by MediFind in the treatment of Ulcerative Colitis. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Ulcerative Colitis, Viral Gastroenteritis, Crohn's Disease, Endoscopy, and Colonoscopy. Dr. Lichtenstein is currently accepting new patients.
Cleveland Clinic Main Campus
Miguel Regueiro is a Gastroenterologist practicing medicine in Cleveland, Ohio. Dr. Regueiro is rated as an Elite provider by MediFind in the treatment of Ulcerative Colitis. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Crohn's Disease, Viral Gastroenteritis, Ulcerative Colitis, Ileostomy, and Colonoscopy. Dr. Regueiro is board certified in American Board Of Internal Medicine, 1997.
Stephen Hanauer is a Gastroenterologist practicing medicine in Chicago, Illinois. He has been practicing medicine for over 49 years. Dr. Hanauer is rated as an Elite provider by MediFind in the treatment of Ulcerative Colitis. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Crohn's Disease, Viral Gastroenteritis, Ulcerative Colitis, Colonoscopy, and Endoscopy. Dr. Hanauer is board certified in American Board Of Internal Medicine - Gastroenterology (Certified).
Summary: The study is an extension of two parent studies (MLN0002-3024 \[NCT04779307\] and MLN0002-3025 \[NCT04779320\]). Participants must have participated in one of the previous studies. The purpose of this study is to collect the long-term safety of vedolizumab in children with UC or CD.
Summary: The study will evaluate patient and Health Care Professional- reported preference for Subcutaneous (SC) compared with IV nivolumab administration or similarly for SC compared with IV pembrolizumab.


